🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
RATIONALE: LY317615 may stop the growth of cancer cells by blocking the enz...
Status
Completed
Location
Jonsson Comprehensive Cancer Center, UCLA
Start Date
2002-12
Trial ID
NCT00052273
Treatments Being Tested
RATIONALE: Enzastaurin may stop the growth of tumor cells by blocking some ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00469976
Treatments Being Tested
The purpose of this study is to assess the effect of enzastaurin (LY317615)...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-08
Trial ID
NCT01388335
Treatments Being Tested
This study is intended for participants with advanced, not amenable to surg...
Status
Terminated
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-09
Trial ID
NCT00538681
Treatments Being Tested
Phase I: A study to see what doses of Enzastaurin and Erlotinib are best to...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2007-05
Trial ID
NCT00452413
Treatments Being Tested
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihor...
Status
Withdrawn
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00685633
Treatments Being Tested
This study will collect further basic safety data on participants with canc...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-03
Trial ID
NCT00309140
Treatments Being Tested
The purpose of this study is to determine the effectiveness of enzastaurin ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2006-11
Trial ID
NCT00386087
Treatments Being Tested
This study will compare the effects of Enzastaurin plus Sunitinib versus Su...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-06-30
Trial ID
NCT00709995
Treatments Being Tested